What is the role of combination therapy in management of zygomycosis?

被引：22
|
作者：
Walsh, Thomas J. [1 ]
Kontoyiannis, Dimitrios P. [2 ]
机构：
[1] NCI, Immunocompromised Host Sect, Pediat Oncol Branch, CRC, Bethesda, MD 20892 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2008年 / 47卷 / 03期
关键词：
D O I：
10.1086/589858
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：372 / 374
页数：3
相关论文
共 50 条
  • [31] Management of symptomatic vertebrobasilar dissection: What is the current role for endovascular therapy and stents?
    Sreenivasan, Sanjeev
    Khandelwal, Priyank
    Nanda, Anil
    Roychowdhury, Sudipta
    Gupta, Gaurav
    INTERVENTIONAL NEURORADIOLOGY, 2023,
  • [32] The role of iron and iron chelators in zygomycosis
    Symeonidis, A. S.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 : 26 - 32
  • [33] What is the rationale for initial treatment with combination therapy?
    Giles, TD
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 264A - 265A
  • [34] Combination Therapy for Mucormycosis: Why, What, and How?
    Spellberg, Brad
    Ibrahim, Ashraf
    Roilides, Emmanuel
    Lewis, Russel E.
    Lortholary, Olivier
    Petrikkos, George
    Kontoyiannis, Dimitrios P.
    Walsh, Thomas J.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 : S73 - S78
  • [35] What is the role of combination drug therapy in the treatment of overactive bladder? ICI-RS 2014
    Visco, Anthony G.
    Fraser, Matthew O.
    Newgreen, Donald
    Oelke, Matthias
    Cardozo, Linda
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 (02) : 288 - 292
  • [36] Combination therapy in epilepsy - When and what to use
    Kwan, Patrick
    Brodie, Martin J.
    DRUGS, 2006, 66 (14) : 1817 - 1829
  • [37] The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
    Mapel, Douglas W.
    Hurley, Judith S.
    Dalal, Anand A.
    Blanchette, Christopher M.
    PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 93 - 103
  • [38] The role of combination pre- and postoperative albendazole therapy in the surgical management of liver hydatidosis
    Yetim, Brahim
    Kilic, Erol
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (06) : 528 - 533
  • [39] Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: A role for combination fibrate therapy
    Fazio, Sergio
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 294 - 306
  • [40] Interferon plus Ribavirin combination therapy influence on platelet count compared with IFN only therapy, what is TPO role?.
    Corbosiero, L
    Tallarico, L
    Acunzo, R
    Divaia, E
    Visconti, M
    Salvio, A
    Varriale, M
    Giannattasio, F
    Fimiani, B
    Dellaguardia, D
    HEPATOLOGY, 1999, 30 (04) : 618A - 618A
12345